9-34459020-T-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7
The NM_012144.4(DNAI1):c.15T>A(p.Ser5Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_012144.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAI1 | NM_012144.4 | c.15T>A | p.Ser5Ser | synonymous_variant | Exon 1 of 20 | ENST00000242317.9 | NP_036276.1 | |
DNAI1 | NM_001281428.2 | c.15T>A | p.Ser5Ser | synonymous_variant | Exon 1 of 20 | NP_001268357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAI1 | ENST00000242317.9 | c.15T>A | p.Ser5Ser | synonymous_variant | Exon 1 of 20 | 1 | NM_012144.4 | ENSP00000242317.4 | ||
DNAI1 | ENST00000614641.4 | c.15T>A | p.Ser5Ser | synonymous_variant | Exon 1 of 20 | 5 | ENSP00000480538.1 | |||
DNAI1 | ENST00000437363.5 | c.15T>A | p.Ser5Ser | synonymous_variant | Exon 1 of 9 | 5 | ENSP00000395396.1 | |||
DNAI1 | ENST00000470982.5 | n.47+1560T>A | intron_variant | Intron 1 of 4 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461862Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727232
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.